New cellular therapy offers hope for multiple myeloma patients

UChicago Medicine is the first program in Chicago to offer Abecma, a cell-based gene therapy for patients with treatment-resistant multiple myeloma.

‘I was going to thrive’: After breast cancer, Bronzeville woman triumphs as a bodybuilder
Breast self-awareness was key to detecting breast cancer